Abstract

We developed and synthesized novel 4-thiazolidinone hybrids with pyridine and pyrazole heterocycles (5a-5o). The structures of the synthesized products were elucidated by IR, 1H NMR and 13C NMR spectroscopy and mass spectrometry. The synthesized hybrids were investigated for their antimicrobial activity against several bacterial and fungal strains using the Mueller–Hinton broth method. Compound 5-(3-methoxybenzylidene)-2-(1-phenyl-3-(p-tolyl)-1H-pyrazol-4-yl)-3-(pyridin-3-yl)thiazolidin-4-one (MIC = 50 μg/mL) exhibited prominent activity against gram-negative E. coli while compounds 5-(2-methylbenzylidene)-2-(1-phenyl-3-(p-tolyl)-1H-pyrazol-4-yl)-3-(pyridin-3-yl)thiazolidin-4-one and 5-(4-methylbenzylidene)-2-(1-phenyl-3-(p-tolyl)-1H-pyrazol-4-yl)-3-(pyridin-3-yl)thiazolidin-4-one exhibited MIC value of 250 μg/mL against C. albicans. Molecular docking study against microbial DNA gyrase could provide valuable insights into the binding modes of these molecules. They were found to exhibit excellent binding affinity (average Glide docking score: −7.989 and binding energy: −49.807 kcal/mol) through significant bonded and non-bonded interactions.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.